UTI AMC
UTI AMC Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
Guidance rank: #25 of 25 in Capital Markets
See the sector's top 10 — free with your mobile number.
What the Q1 FY27 call signalled
1 of 3 strong
The short version
UTI AMC targets to manage 2x current AUM by 2031, with current staffing and technology investments supporting this growth. Management refrains from giving specific earnings or profit guidance beyond FY26-27, indicating uncertainty about short-term outlook.
From UTI AMC's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- UTI AMC targets to manage 2x current AUM by 2031, with current staffing and technology investments supporting this growth.
- Q1 FY27 showed strong momentum with quarterly average AUM nearing Rs 4,00,000 crores, a 12.6% YoY industry growth.
- Robust product pipeline includes passive products like UTI Nifty 500 ETF and new active offerings (balanced hybrid, sectoral debt funds).
- Plans to launch SIF and GIFT City outbound funds in H2 FY27 to tap new growth areas.
- Emphasis on expanding SIP franchise and investor reach, adding 3.89 lakh folios and 2.51 lakh new investors in Q1.
- Improved digital capabilities driving 23.93% YoY growth in digital purchase transactions.
2 more points from UTI AMC's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what UTI AMC said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- UTI AMC is expanding both passive and active investment offerings with new product launches, including UTI Nifty 500 ETF, UTI BSE Index Sector Leaders ETF, balanced hybrid funds, sectoral debt funds, and GIFT City outbound funds planned in H2 FY27.
- The company completed major IT and digital initiatives (digital asset revamp, cloud infrastructure, Salesforce automation, data lake) with no significant additional capital expense expected this financial year; modest 8%-10% increase in IT/digital spend targeted for FY27.
- Strategic investments include doubling headcount in UTI Pension Fund over the next 18 months to support private pension business growth.
2 more points from UTI AMC's call on capex
Create a free account to keep reading this call
Top-ranked in Capital Markets
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what UTI AMC said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from UTI AMC's call on order book
Create a free account to keep reading this call
UTI AMC — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹415 Cr, net profit ₹132 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What UTI AMC's management said in earlier quarters
- Q2 FY27 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q4 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY23 earnings call →
- Q2 FY23 earnings call →
Others in Capital Markets this season
- Pune e-Stock Broking (Q1 FY27)
For H2 FY26, Revenue from Operations was ₹27.5 Crore, up 20.4% YoY from ₹22.8 Crore in H2 FY25. Key investor presentation takeaways from Pune e-Stock Broking Lt
- Almondz Global (Q1 FY27)
INR 130 Crores for FY26 (Page 10). Key investor presentation takeaways from Almondz Global's Q1 FY27 investor presentation — and how it ranks against sector pee
- Indo Thai Sec. (Q1 FY27)
Q4 FY26 Total Revenue: ₹38.41 Cr, up 548% YoY from ₹5.93 Cr in Q4 FY25 (Page 15). Key investor presentation takeaways from Indo Thai Securities's Q1 FY27 invest
- CARE Ratings (Q1 FY27)
111.68 Cr, up 18.9% YoY (Page 2, 13) . Key concall takeaways from CARE Ratings Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
Potential multibaggers · Q2 FY27
Potential multibaggers in Capital Markets
on management's own guidance
- Nippon Life India Asset Management LtdGood growth2
- BSEGood growth1
- Motilal Oswal Financial Services LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
UTI AMC and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were UTI AMC Q1 FY27 results?
UTI AMC targets to manage 2x current AUM by 2031, with current staffing and technology investments supporting this growth. Management refrains from giving specific earnings or profit guidance beyond FY26-27, indicating uncertainty about short-term outlook.
What is UTI AMC share price analysis?
UTI AMC currently shows a neutral. The stock trades at a P/E of 21.5 with a market cap of ₹11,479 Cr. Investors should review the full earnings analysis for detailed insights.
Is UTI AMC planning capital expenditure?
UTI AMC is expanding both passive and active investment offerings with new product launches, including UTI Nifty 500 ETF, UTI BSE Index Sector Leaders ETF, balanced hybrid funds, sectoral debt funds, and GIFT City outbound funds planned in H2 FY27.
Keep UTI AMC on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.